Kamdar Kim P.

CIK 000153506520 companiesSALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001535065

Recent Transactions

50 trades

Other
SERA PROGNOSTICS, INC.$SERA
Class A Common Stock
2026-02-04+3,231→ 32,573 total
Other
SERA PROGNOSTICS, INC.$SERA
Class A Common Stock
2026-02-04−30,920→ 0 total
Award
SERA PROGNOSTICS, INC.$SERA
Stock Option (right to buy)
2025-06-05+25,000→ 25,000 total
Award
SERA PROGNOSTICS, INC.$SERA
Class A Common Stock
2025-06-05+15,596→ 29,342 total
Disposition to Issuer
Singular Genomics Systems, Inc.
Common Stock
2025-02-21−3,763,985→ 0 total
Disposition to Issuer
Singular Genomics Systems, Inc.
Stock Option (Right to Buy)
2025-02-21−2,466→ 0 total
Disposition to Issuer
Singular Genomics Systems, Inc.
Stock Option (Right to Buy)
2025-02-21−1,541→ 0 total
Disposition to Issuer
Singular Genomics Systems, Inc.
Stock Option (Right to Buy)
2025-02-21$8.84/sh−2,466→ 0 total
Disposition to Issuer
Singular Genomics Systems, Inc.
Common Stock
2025-02-21−15,000→ 0 total
Disposition to Issuer
Singular Genomics Systems, Inc.
Stock Option (Right to Buy)
2025-02-21−666→ 0 total
Disposition to Issuer
Singular Genomics Systems, Inc.
Common Stock
2025-02-21−15,000→ 0 total
Award
SERA PROGNOSTICS, INC.$SERA
Class A Common Stock
2024-06-06+7,117→ 13,746 total
Award
SERA PROGNOSTICS, INC.$SERA
Stock Option (right to buy)
2024-06-06+10,549→ 10,549 total
Award
Singular Genomics Systems, Inc.
Stock Option (Right to Buy)
2024-05-29+74,000→ 74,000 total
Sale
Evofem Biosciences, Inc.$EVFM
Common Stock
2023-12-21$0.62/sh−10→ 0 total
Sale
Singular Genomics Systems, Inc.
Common Stock
2023-08-15$0.53/sh−200,000→ 3,763,985 total
Sale
Singular Genomics Systems, Inc.
Common Stock
2023-08-14$0.57/sh−77,991→ 3,963,985 total
Sale
Singular Genomics Systems, Inc.
Common Stock
2023-08-11$0.60/sh−353,657→ 4,041,976 total
Award
SERA PROGNOSTICS, INC.$SERA
Stock Option (right to buy)
2023-06-08+63,265→ 63,265 total
Award
Singular Genomics Systems, Inc.
Stock Option (Right to Buy)
2023-05-25+74,000→ 74,000 total
Award
SERA PROGNOSTICS, INC.$SERA
Stock Option (right to buy)
2022-06-03+149,675→ 149,675 total
Award
Singular Genomics Systems, Inc.
Stock Option (Right to Buy)
2022-05-26+46,250→ 46,250 total
Award
Evofem Biosciences, Inc.$EVFM
Stock option (right to buy)
2022-05-04+6,000→ 6,000 total
Purchase
Evofem Biosciences, Inc.$EVFM
Common Stock
2021-06-18$1.17/sh+10,000→ 19,287 total
Conversion
Singular Genomics Systems, Inc.
Series A Convertible Preferred Stock
2021-06-01−1,293,243→ 0 total
Conversion
Singular Genomics Systems, Inc.
Series Seed Convertible Preferred Stock
2021-06-01−2,666,781→ 0 total
Conversion
Singular Genomics Systems, Inc.
Common Stock
2021-06-01+4,395,633→ 4,495,633 total
Conversion
Singular Genomics Systems, Inc.
Series B Convertible Preferred Stock
2021-06-01−435,609→ 0 total
Award
Evofem Biosciences, Inc.$EVFM
Stock option (right to buy)
2021-05-12+90,000→ 90,000 total
Award
Vyome Holdings, Inc$HIND
Stock Option
2020-09-16+27,250→ 27,250 total
Award
Vyome Holdings, Inc$HIND
Stock Option (Right to Buy)
2020-09-16+27,250→ 27,250 total
Purchase
Evofem Biosciences, Inc.$EVFM
Common Stock
2020-06-12$2.94/sh+5,000→ 9,287 total
Award
Evofem Biosciences, Inc.$EVFM
Stock option (right to buy)
2020-05-12+50,000→ 50,000 total
Purchase
Vyome Holdings, Inc$HIND
Common Stock
2019-08-06$4.00/sh+12,500→ 27,148 total
Purchase
Vyome Holdings, Inc$HIND
Warrants to Purchase Common Stock
2019-08-06$4.00/sh+9,375→ 9,375 total
Award
Vyome Holdings, Inc$HIND
Common Stock
2019-07-23+78,125→ 146,470 total
Award
Evofem Biosciences, Inc.$EVFM
Stock Option (Right to Buy)
2019-06-05+50,000→ 50,000 total
Other
Evofem Biosciences, Inc.$EVFM
Common Stock
2019-05-22+4,287→ 4,287 total
Sale
Evofem Biosciences, Inc.$EVFM
Common Stock
2019-05-21$5.07/sh−655→ 0 total
Purchase
Vyome Holdings, Inc$HIND
Common Stock
2018-08-23$1.82/sh+54,945→ 68,345 total
Award
Vyome Holdings, Inc$HIND
Stock Option (Right to Buy)
2018-06-13+81,774→ 81,774 total
Award
Evofem Biosciences, Inc.$EVFM
Stock Option (Right to Buy)
2018-05-08+12,875→ 12,875 total
Award
Evofem Biosciences, Inc.$EVFM
Stock Option (Right to Buy)
2017-06-20+12,450→ 12,450 total
Award
Vyome Holdings, Inc$HIND
Stock Option (Right to Buy)
2017-06-06+36,554→ 36,554 total
Award
Evofem Biosciences, Inc.$EVFM
Stock Option (Right to Buy)
2017-05-11+63,500→ 63,500 total
Award
Vyome Holdings, Inc$HIND
Stock Option (Right to Buy)
2017-05-09+21,000→ 21,000 total
Award
Vyome Holdings, Inc$HIND
Stock Option (Right to Buy)
2016-11-09+46,500→ 46,500 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2016-10-31+8,000→ 8,000 total
Purchase
Vyome Holdings, Inc$HIND
Common Stock
2016-10-12$15.00/sh+13,400→ 13,400 total
Award
Evofem Biosciences, Inc.$EVFM
Stock Option (Right to Buy)
2016-06-21+12,450→ 12,450 total

Recent Filings

Address

C/O SERA PROGNOSTICS, INC. 2749 EAST PARLEYS WAY, SUITE 200

SALT LAKE CITY, UT, 84109

View on SEC.gov